生物
PDX1型
转录组
间质细胞
计算生物学
癌症研究
间充质干细胞
生物信息学
遗传学
基因
转录因子
基因表达
作者
Kevin Yang,Steve E. Kalloger,John James Aird,Michael K.C. Lee,Christopher K. Rushton,Karen L. Mungall,Andrew J. J. Mungall,Dongxia Gao,Christine Chow,Jing Xu,Joanna M. Karasinska,Shane Colborne,Steven J.M. Jones,Joerg Schrader,Ryan D. Morin,Jonathan M. Loree,Marco A. Marra,Daniel John Renouf,Gregg B. Morin,David F. Schaeffer
出处
期刊:Cell Reports
[Cell Press]
日期:2021-10-01
卷期号:37 (2): 109817-109817
被引量:44
标识
DOI:10.1016/j.celrep.2021.109817
摘要
Pancreatic neuroendocrine neoplasms (PNENs) are biologically and clinically heterogeneous. Here, we use a multi-omics approach to uncover the molecular factors underlying this heterogeneity. Transcriptomic analysis of 84 PNEN specimens, drawn from two cohorts, is substantiated with proteomic profiling and identifies four subgroups: Proliferative, PDX1-high, Alpha cell-like and Stromal/Mesenchymal. The Proliferative subgroup, consisting of both well- and poorly differentiated specimens, is associated with inferior overall survival probability. The PDX1-high and Alpha cell-like subgroups partially resemble previously described subtypes, and we further uncover distinctive metabolism-related features in the Alpha cell-like subgroup. The Stromal/Mesenchymal subgroup exhibits molecular characteristics of YAP1/WWTR1(TAZ) activation suggestive of Hippo signaling pathway involvement in PNENs. Whole-exome sequencing reveals subgroup-enriched mutational differences, supported by activity inference analysis, and identifies hypermorphic proto-oncogene variants in 14.3% of sequenced PNENs. Our study reveals differences in cellular signaling axes that provide potential directions for PNEN patient stratification and treatment strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI